Fig. 6 | Scientific Reports

Fig. 6

From: DGCR2 targeting affibody molecules for delivery of drugs and imaging reagents to human beta cells

Fig. 6The alternative text for this image may have been generated using AI.

(A) Uptake of Indium-111 labeled Affibody molecules in kidney, urine and blood, based on ex vivo gamma counter measurements of excised tissues. (B) Biodistribution of [68Ga]ZDGCR2:AM106 by ex vivo organ distribution 60 min after injection. (C) Representative coronal PET/CT projections at 5 min, 30 min and 60 min after injection of [68Ga]ZDGCR2:AM106. (B) Biodistribution of [68Ga]ZDGCR2:AM106 in individual organs over time, from quantitative PET/CT scans.

Back to article page